Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients With Rabeprazole

ClinicalTrials.gov ID: NCT00132496

Public ClinicalTrials.gov record NCT00132496. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 8:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety and Efficacy of Rabeprazole in the Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to collect safety information on rabeprazole 10 mg and 20 mg in the treatment of gastroesophageal reflux disease (GERD) in children aged 12 to 16 years. The secondary objectives are to assess the efficacy of rabeprazole on the improvement of the symptoms of GERD and to explore the relationship of symptom relief to dose received, based on symptom frequency and severity, antacid use, and quality of life (QOL) measures.

Study identification

NCT ID
NCT00132496
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eisai Inc.
Industry
Enrollment
111 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years to 16 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2005
Primary completion
Apr 30, 2006
Completion
Jun 30, 2006
Last update posted
Dec 2, 2009

2005 – 2006

United States locations

U.S. sites
25
U.S. states
16
U.S. cities
24
Facility City State ZIP Site status
Longmont Medical Research Network Longmont Colorado 80501
Nova Southeastern University Fort Lauderdale Florida 33328
Babies and Beyond Peds New Port Richey Florida 34652
Dr. Patricia Barrington, Dr. B. Abraham, PC Snellville Georgia 30039
Multi-specialty Clinical Research Hoffman Estates Illinois 60194
Kentucky Pediatric/Adult Research Bardstown Kentucky 40004
Professional Clinical Research Cadillac Michigan 49601
Community Pediatric Associates Kalamazoo Michigan 49008
The Center for Human Nutrition Omaha Nebraska 68105
Children's Hospital of Buffalo - Digestive Disease And Nutrition Center Buffalo New York 14222
Winthrop University Hospital Mineola New York 11501
Pediatric Associates of Mount Carmel, Inc. Cincinnati Ohio 45245
Pediatric Associates of Mt. Carmel Cincinnati Ohio 45245
University of Pediatrics Mason Ohio 45040
Center for Children's Digestive Health Youngstown Ohio 44514
Pharmacotherapy Research Associates Zanesville Ohio 43701
Biomedical Research Associates Shippensburg Pennsylvania 17257
DeGarmo Institute of Medicine Research Greer South Carolina 29651
Focus Research Group Hendersonville Tennessee 37075
ProMed Healthcare Johnson City Tennessee 37601
NE Ohio University College of Medicine Lebanon Tennessee 37087
Southwest Children's Research Associates San Antonio Texas 78229
Alpine Medical Group Salt Lake City Utah 84102
Rockwood Clinic North Spokane Washington 99202
Marshall University Huntington West Virginia 25701

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00132496, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 2, 2009 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00132496 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →